About Company Leadership Portfolio Catalog Compliance Contact Get in Touch
Mumbai, India · Est. 2019 · Active

Wholesale Trade
Delivered with
Purpose.

Reborn Exports Private Limited is a registered wholesale enterprise based in Mumbai, engaged in diversified trade across specialized categories — including WHO-GMP certified pharmaceutical exports.

2019
Incorporated
₹10L
Auth. Capital
54
Formulations
Active
MCA Status
Raltegravir Dolutegravir TDF/3TC/DTG Darunavir/Ritonavir Bictegravir/TAF/FTC Tenofovir Alafenamide Favipiravir Oseltamivir Efavirenz Abacavir/Lamivudine Raltegravir Dolutegravir TDF/3TC/DTG Darunavir/Ritonavir Bictegravir/TAF/FTC
RE
2019
Year Founded
Mumbai, India
Who We Are

A Trusted Wholesale Enterprise in the Heart of Mumbai

Reborn Exports Private Limited is a privately held company incorporated under the Companies Act, 2013. Registered at the Registrar of Companies, Mumbai, we operate in the wholesale trade space covering a variety of goods and specializations — including WHO-GMP certified pharmaceutical exports for national procurement, NGO, and healthcare-distributor supply chains.

  • Engaged in Other Wholesale Trade (NIC 5190) — diversified goods without particular specialization, including pharmaceutical exports
  • Registered and active under the Ministry of Corporate Affairs, Government of India
  • Pharmaceutical portfolio: 54 WHO-GMP formulations across 4 therapeutic groups, manufactured by Mcneil & Argus Pharmaceuticals Limited
  • Secured credit facility of ₹25,00,000 with Canara Bank (Charge created Sept 2023)
  • No prosecutions on record — clean regulatory standing
  • Directors hold active roles across energy, hospitality, wellness, and innovation sectors
Corporate Identity

Company Information

Official details as registered with the Ministry of Corporate Affairs, Government of India.

CIN
U51909MH2019PTC326722
Company Status
Active
Registration No.
326722
Date of Incorporation
13 December 2019
Class of Company
Private
Company Category
Limited by Shares
Sub Category
Non-Government
ROC
ROC, Mumbai
Listed on Exchange
Unlisted
NIC Code
5190 — Wholesale
Authorised Capital
₹ 10,00,000
Paid-up Capital
₹ 10,000
Leadership

Board of Directors

The company is guided by experienced directors with active interests across multiple sectors including energy, wellness, and hospitality.

KJ
Kiran Jain
Director
DIN: 00887368
Appointed: 16 March 2023
AJ
Anita Kiran Jain
Director
DIN: 08481531
Appointed: 13 June 2019
Past Directors
R
Rakhi Ceased
DIN: 08481532 · Cessation: 10 March 2023
Secured Loans

Charges & Credit Facilities

Active charges (secured loans) registered against the company with the Registrar of Companies.

Canara Bank — Secured Charge
Charge ID: 100825047
Charge Amount
₹ 25,00,000
Charge Holder
Canara Bank
Date of Creation
14 September 2023
Modification
Closure
Status
Open
Pharmaceutical Exports

The Product Range We Cater

Our portfolio comprises 54 formulations spanning single-entity therapy, fixed-dose combinations, pediatric formulations and broader antivirals — covering first-line through advanced HIV/AIDS treatment regimens, as well as influenza and Hepatitis C support. Manufactured by Mcneil & Argus Pharmaceuticals Limited, a WHO-GMP & ISO 9001:2015 certified facility.

Single Entity ART

17 FORMULATIONS

Our single-entity range covers every major antiretroviral class — Raltegravir, Darunavir, Dolutegravir, Rilpivirine, Tenofovir (TAF and TDF), Ritonavir, Abacavir, Atazanavir, Efavirenz and Nevirapine — giving procurement teams the flexibility to build custom regimens or supplement therapy already in place.

Combination ART (Fixed-Dose)

22 FORMULATIONS

Fixed-dose combinations are the core of our portfolio. These 2- and 3-drug combinations, including WHO-preferred single-tablet regimens such as TDF/3TC/DTG, are designed to reduce pill burden and improve adherence — a priority for national treatment programs operating at scale.

Pediatric Formulations & Oral Solutions

10 FORMULATIONS

Ten formulations dedicated to pediatric care: weight-banded tablets and oral liquids covering Zidovudine, Lamivudine, Abacavir, Nevirapine, Lopinavir/Ritonavir and Efavirenz, alongside Oseltamivir suspensions. Several support standard PMTCT protocols in maternal and neonatal care settings.

Antivirals (Non-HIV)

5 FORMULATIONS

Beyond HIV, we supply Favipiravir, Ribavirin and three strengths of Oseltamivir — supporting seasonal and pandemic influenza response, outbreak stockpiling, and combination therapy for chronic Hepatitis C.

54
Formulations
4
Therapeutic Groups
6
Dosage Formats
100%
WHO-GMP Certified
Complete Range

Product Catalog

54 WHO-GMP certified formulations. Search, filter, and explore the full portfolio.

Governance

Annual Compliance

Regulatory compliance records as maintained with the Ministry of Corporate Affairs.

Company StatusActive
Last Annual General Meeting (AGM)30 December 2023
Last Balance Sheet Filed31 March 2023
Number of Members0
Prosecution RecordsNone
Outstanding Payments to MSMEsNone on Record
Investor / Director ComplaintsNone
Data as of30 June 2024
Reach Us

Contact & Location

📍
Registered Address
1, Floor 2nd, 6, Amrutanjan House,
R S Navalkar Lane, Tadwadi Chirabazar,
Kalbadevi, Mumbai – 400 002
Maharashtra, India
General Email
💊
Export Division
+91 22 4000 1180
🏛
Jurisdiction
Registrar of Companies, Mumbai
Ministry of Corporate Affairs, India
Corporate Identification Number
U51909MH2019PTC326722
Registration Number
326722
Business Activity
NIC Code 5190 — Other Wholesale Trade: Specialized wholesale not covered in any one category, and wholesale in a variety of goods without particular specialization. Includes WHO-GMP certified pharmaceutical exports.
Directors
Kiran Jain (DIN: 00887368)
Anita Kiran Jain (DIN: 08481531)
Company Type
Private Limited — Non-Government — Unlisted